Viewing Study NCT00330278



Ignite Creation Date: 2024-05-05 @ 4:53 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00330278
Status: COMPLETED
Last Update Posted: 2007-09-27
First Post: 2006-05-25

Brief Title: Timing of Prophylactic Antibiotics for Cesarean Sections
Sponsor: Medical University of South Carolina
Organization: Medical University of South Carolina

Study Overview

Official Title: A Randomized Double-Blind Placebo Controlled Trial of Cefazolin Given Either 30 Minutes Prior to Cesarean Section or at Cord Clamping
Status: COMPLETED
Status Verified Date: 2006-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a randomized double-blinded placebo controlled trial of cefazolin timing before cesarean section fo infection prophylaxis Subjects are randomized to cefazolin either 30 minutes prior to skin incision or at time of cord-clamping Primary outcome is infectious morbidity including wound infections and endometritis
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None